corporary

IGEPHARMA

Active
SIREN 404085060 VAT number FR20404085060

Business purpose.

Fabrication de produits pharmaceutiques, diététiques, cosmétiques et vétérinaires ; conception, commercialisation et courtage de produits pharmaceutiques, diététiques, cosmétiques et vétérinaires

IGEPHARMA is a company registered under SIREN number 404085060, with its registered office in SAINT-BEAUZIRE. Its main activity falls under the sector: Manufacture of basic pharmaceutical products and pharmaceutical preparations. 1 serving director is recorded in the national business register. Its reported revenue for the financial year ended in 2026 is 0 euros.

Sources: INSEE Sirene, INPI RNE, INPI, annual accounts.

Identity

Legal form
SARL (no further detail)
Activity
Manufacture of pharmaceutical preparations (21.20Z)
Sector
Manufacture of basic pharmaceutical products and pharmaceutical preparations
Headcount
20 to 49 employees
Created
20 Feb 1996
Share capital
46,000.00 EUR
Registered with the trade register
27 Feb 1996
Financial year end
31/01
Establishments
1

Directors

Related companies

Companies run by the same people. Statutory auditors and liquidators are excluded: they serve in dozens of unrelated companies, and including them would draw groups that do not exist.

Other companies at the same address

36 other company head offices are registered at this address.

Establishments

Financial strength

Financial score

75 / 100 B

Confidence: medium · computed on the financial year ended 31 Jan 2026

Equity to assets (65.4 %)
23.0 out of 30
EBITDA margin
data missing, component not taken into account
Liquidity (294.9 %)
11.8 out of 20
Debt (5.3 %)
14.1 out of 15
Revenue trend
data missing, component not taken into account

formula fin-1.0

Legal score

100 / 100 A

Confidence: high

No insolvency proceedings
40.0 out of 40
Currently trading
20.0 out of 20
Age (30.7 years)
20.0 out of 20
Accounts filed recently
20.0 out of 20

formula leg-1.0

These scores are computed by us from public data, using a published formula. They are not advice, not a guarantee, not a credit decision, and they do not replace a review of the accounts. See how it is calculated

Revenue and earnings

Detailed accounts for this company are not reproduced here, but its main aggregates are public.

Revenue and net income by financial year
2022 2023 2024 2025 2026

Revenue Net income

Financial year Revenue Change EBITDA Net income
31 Jan 2026 0 € — 0 € 189,506 €
31 Jan 2025 0 € — 0 € 162,625 €
31 Jan 2024 0 € — 0 € 283,234 €
31 Jan 2023 0 € — 0 € 151,812 €
31 Jan 2022 0 € first year on record 0 € 144,640 €

Aggregates published by the French Directorate General for Enterprise, computed from accounts filed with the commercial court.

Explore similar companies

Collective agreements

Agreements declared by the employer in its payroll filings.

  • Convention collective nationale de la fabrication et du commerce des produits à usage pharmaceutique, parapharmaceutique et vétérinaire du 1er juin 1989. Etendue par arrêté du 20 avril 1990 JORF 29 avril 1990

    IDCC 1555 · repealed · 1 establishment · declared in August 2026

Legal notices

  • Filing of accounts 31 Aug 2026
    Court :
    Greffe du Tribunal de Commerce de clermont-ferrand
    Type of filing :
    Comptes annuels et rapports
    Closing date :
    31/01/2026

    BODACC C n 20260166, annonce n 2640 · Proof of publication (PDF)

  • Filing of accounts 5 Aug 2025
    Court :
    Greffe du Tribunal de Commerce de clermont-ferrand
    Type of filing :
    Comptes annuels et rapports
    Closing date :
    31/01/2023

    BODACC C n 20250148, annonce n 6369 · Proof of publication (PDF)

  • Filing of accounts 5 Aug 2025
    Court :
    Greffe du Tribunal de Commerce de clermont-ferrand
    Type of filing :
    Comptes annuels et rapports
    Closing date :
    31/01/2024

    BODACC C n 20250148, annonce n 6370 · Proof of publication (PDF)

  • Filing of accounts 5 Aug 2025
    Court :
    Greffe du Tribunal de Commerce de clermont-ferrand
    Type of filing :
    Comptes annuels et rapports
    Closing date :
    31/01/2025

    BODACC C n 20250148, annonce n 6371 · Proof of publication (PDF)

  • Filing of accounts 5 Aug 2025
    Court :
    Greffe du Tribunal de Commerce de clermont-ferrand
    Type of filing :
    Comptes annuels et rapports
    Closing date :
    31/01/2022

    BODACC C n 20250148, annonce n 6368 · Proof of publication (PDF)

  • Amendment 29 Jul 2025
    Court :
    Greffe du Tribunal de Commerce de Clermont-Ferrand
    Amendment :
    Modification survenue sur l'administration.

    BODACC B n 20250143, annonce n 3667 · Proof of publication (PDF)

Annual accounts as PDF →

Filings and accounts

  • Formality 28 Jul 2025
  • Formality 23 Jul 2025
  • Formality 18 Jul 2025

Change history

  • officer_appointed (empty) → Gerant 9 Oct 2026
  • registered_address (empty) → Biopôle Clermont Limagne Rond Point du Biopôle 63360 Saint-Beauzire 2 Oct 2026

Frequently asked questions about IGEPHARMA

What is the SIREN number of IGEPHARMA?
The SIREN number of IGEPHARMA is 404085060. Its intra-community VAT number is FR20404085060.
Where is the head office of IGEPHARMA?
Head office address: BIOPOLE CLERMONT LIMAGNE, 63360 SAINT-BEAUZIRE.
When was IGEPHARMA founded?
IGEPHARMA was founded on 20 Feb 1996.
What does IGEPHARMA do?
Its declared main activity is: Manufacture of pharmaceutical preparations (NAF code 21.20Z).
Who runs IGEPHARMA?
The officer listed in the register is DOMINIQUE PAULET (Gerant).
What is the revenue of IGEPHARMA?
The latest published revenue is 0 €, for the 2026 financial year.
How many employees does IGEPHARMA have?
The declared headcount is 20 to 49 employees. Insee data for 2024.
Is IGEPHARMA subject to insolvency proceedings?
No ongoing insolvency proceedings are published in the BODACC for this company.

In the official registers

Further reading

Show this profile on your website →

Report an error or request removal of this data